Recent insider trading activity from Smith Lillian, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2023 | Allogene Therapeutics, Inc. | $ALLO | Smith Lillian | VP, Corporate Counsel | A | Common Stock | 56545 | $0.00 | 140,390.0000 | 0 | 67.44% | 0.00% |